Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center

Background— The diagnosis of infective endocarditis (IE) in prosthetic valves and intracardiac devices is challenging because both the modified Duke criteria (DC) and echocardiography have limitations in this population. The added value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and 18F-FDG PET/CT angiography (PET/CTA) was evaluated in this complex scenario at a referral center with a multidisciplinary IE unit. Methods and Results— Ninety-two patients admitted to our hospital with suspected prosthetic valve or cardiac device IE between November 2012 and November 2014 were prospectively included. All patients underwent echocardiography and PET/CT, and 76 had cardiac CTA. PET/CT and echocardiography findings were evaluated and compared, with concordant results in 54% of cases (&kgr;=0.23). Initial diagnoses with DC at admission, PET/CT, and DC+PET/CT were compared with the final diagnostic consensus reached by the IE Unit. DC+PET/CT enabled reclassification of 90% of cases initially classified as possible IE with DC and provided a conclusive diagnosis (definite/rejected) in 95% of cases. Sensitivity, specificity, and positive and negative predictive values were 52%, 94.7%, 92.9%, and 59.7% for DC; 87%, 92.1%, 93.6%, and 84.3% for PET/CT; and 90.7%, 89.5%, 92%, and 87.9% for DC+PET/CT. Use of PET/CTA yielded even better diagnostic performance values than PET/nonenhanced CT (91%, 90.6%, 92.8%, and 88.3% versus 86.4%, 87.5%, 90.2%, and 82.9%) and substantially reduced the rate of doubtful cases from 20% to 8% (P<0.001). DC+PET/CTA reclassified an additional 20% of cases classified as possible IE with DC+PET/nonenhanced CT. In addition, PET/CTA enabled detection of a significantly larger number of anatomic lesions associated with active endocarditis than PET/nonenhanced CT (P=0.006) or echocardiography (P<0.001). Conclusions— 18F-FDG PET/CT improves the diagnostic accuracy of the modified DC in patients with suspected IE and prosthetic valves or cardiac devices. PET/CTA yielded the highest diagnostic performance and provided additional diagnostic benefits.

[1]  J. M. Miró,et al.  Organization and Functioning of a Multidisciplinary Team for the Diagnosis and Treatment of Infective Endocarditis: A 30-year Perspective (1985-2014) Organizacion y funcionamiento de un grupo multidisciplinario de diagnostico y tratamiento de la endocarditis infecciosa: perspectiva de 30 anos (1985- , 2016 .

[2]  J. Miro,et al.  Organization and Functioning of a Multidisciplinary Team for the Diagnosis and Treatment of Infective Endocarditis: A 30-year Perspective (1985-2014). , 2015, Revista espanola de cardiologia.

[3]  J. Rodríguez-Palomares,et al.  Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices with F-FDG-PET/CT-Angiography: Initial Results at an Infective Endocarditis Referral Center , 2015 .

[4]  B. Iung,et al.  Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis , 2014, The Journal of Nuclear Medicine.

[5]  A. Thomassen,et al.  Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis. , 2014, European heart journal cardiovascular Imaging.

[6]  E. Bouza,et al.  Role of 18F-FDG PET in Patients with Infectious Endocarditis , 2014, The Journal of Nuclear Medicine.

[7]  G. Boriani,et al.  Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  L. Leccisotti,et al.  Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging , 2014, Journal of Nuclear Cardiology.

[9]  P. Erba,et al.  Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. , 2013, JACC. Cardiovascular imaging.

[10]  P. Mas,et al.  Epidemiología de la endocarditis infecciosa en España en los últimos 20 años , 2013 .

[11]  P. Tornos Mas,et al.  Focus on : Epidemiology of Cardiovascular Disease in Spain Over the Past 20 Years ( IV ) Epidemiology of Infective Endocarditis in Spain in the Last 20 Years , 2017 .

[12]  D. Raoult,et al.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. , 2013, Journal of the American College of Cardiology.

[13]  V. Ambrosini,et al.  18F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  P. Christian,et al.  EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection* , 2013, The Journal of Nuclear Medicine.

[15]  J. Carr,et al.  Imaging of infective endocarditis with cardiac CT angiography. , 2012, Journal of cardiovascular computed tomography.

[16]  P. Erba,et al.  Added Value of 99mTc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis , 2012, The Journal of Nuclear Medicine.

[17]  I. Nault,et al.  Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. , 2012, Journal of the American College of Cardiology.

[18]  J. Le Heuzey,et al.  Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  W. Oyen,et al.  Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques , 2010, The Journal of Nuclear Medicine.

[20]  S. Dymarkowski,et al.  18F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  B. Albat,et al.  Preoperative evaluation in aortic endocarditis: findings on cardiac CT. , 2010, AJR. American journal of roentgenology.

[22]  J. Zamorano,et al.  Recommendations for the practice of echocardiography in infective endocarditis. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[23]  J. Ellis,et al.  Reducing the risk of contrast-induced nephropathy: a perspective on the controversies. , 2009, AJR. American journal of roentgenology.

[24]  S. Ben-Haim,et al.  Cardiovascular infection and inflammation. , 2009, Seminars in nuclear medicine.

[25]  André Plass,et al.  Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. , 2009, Journal of the American College of Cardiology.

[26]  P. Seferovic The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) , 2009 .

[27]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[28]  B. Mulder,et al.  Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[29]  V. Fuster,et al.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.

[30]  Xavier Duval,et al.  Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  G. V. von Schulthess,et al.  Infection imaging using whole-body FDG-PET , 2000, European Journal of Nuclear Medicine.

[32]  R. Gamelli,et al.  Augmentations of glucose uptake and glucose transporter‐1 in macrophages following thermal injury and sepsis in mice , 1996, Journal of leukocyte biology.

[33]  W. Dismukes,et al.  Management of infective endocarditis. , 1981, Cardiovascular clinics.